Estrogen-like effects of cadmium (Cd) have been reported in several animal studies, and recent epidemiological findings suggest increased risk of hormone-dependent cancers after Cd exposure. The mechanisms underlying these effects are still under investigation. Our aim was to study the effects of Cd on cellular signaling pathways in vivo with special focus on estrogen signaling and to perform benchmark dose analysis on the effects. Transgenic adult ERE-luciferase male mice were exposed subcutaneously to 0.5-500 mg CdCl 2 per kg body weight (bw) or 17a-ethinylestradiol (EE2) for 3 days. These doses had no effects on organ and bw or testicular histology, indicating subtoxic exposure levels. The transgene luciferase, reporting genomic estrogen response, was significantly increased by EE2 but not by Cd. However, Cd significantly affected kinase phosphorylation and endogenous gene expression. Interestingly, gene expression changes displayed a traditional dose-response relationship, with benchmark dose levels for the expression of Mt1, Mt2, p53, and Mdm2 being 92.9, 19.9, 7.6, 259, and 25.9 mg/kg bw, respectively, but changes in kinase phosphorylation were only detected at low exposure levels. Phosphorylation of Erk1/2 was significantly increased even in the lowest dose group, 0.5 mg/kg bw, rendering pErk1/2 a more sensitive sensor of exposure than changes in gene expression. Collectively, our data suggest that the effects triggered by Cd in vivo are markedly concentration dependent. Furthermore, we conclude that the estrogen-like effects of Cd are likely to result from a mechanism different from steroidal estrogens.
Cadmium (Cd) is a toxic metal of occupational and environmental concern (Järup and Å kesson, 2009 ). Based on data from occupationally exposed individuals, Cd has been classified as a category 1 (human) carcinogen by the International Agency for Research on Cancer (IARC) (1993) . Epidemiological findings and experimental studies on animals published so far suggest that Cd is involved in the carcinogenicity of multiple organs including lung, kidney, liver, pancreas, urinary bladder, breast, and prostate (Huff et al., 2007) . Recent reports suggest endocrine modulative properties at low environmentally relevant exposure levels (Byrne et al., 2009) .
Research on endocrine modulatory effects of Cd started over a decade ago when the ability of this metal to evoke estrogenic responses was first discovered (Garcia-Morales et al., 1994; Stoica et al., 2000) . Although several independent cell culture-based studies have shown estrogen-like activity of Cd in terms of proliferation and gene expression (Brama et al., 2007; Jin et al., 2003; Siewit et al., 2010) , in particular the in vivo estrogenicity has turned out to be difficult to reproduce. Initially, Johnson et al. (2003) reported that a single ip dose of 5 lg/kg body weight (bw) increased the uterine wet weight and stimulated mammary epithelium growth in ovariectomized Sprague Dawley rats. Since then, 100-fold higher CdCl 2 concentrations have been required to produce similar effects in rats (Höfer et al., 2009; Zhang et al., 2007) . In addition, some reports have emerged where no uterotrophic or proliferative effects of Cd was detected (Ali et al., 2010; Höfer et al., 2009; Pillet et al., 2006; Silva et al., 2006) . The scanty information on the exact mechanism of action for the endocrine modulatory effects of Cd hampers the interpretation of these seemingly contradictory results.
Estrogens exert many of their physiological actions by activating their target genes via estrogen receptors ERa and ERb. Activation of nuclear ER induces transcriptional responses, while nongenomic signaling originating from cell membranes, perhaps via membrane bound ERs, results in activation of phosphorylation cascades through, e.g., mitogen-activated protein kinases (MAPKs), and/or Akt pathways (Moriarty et al., 2006; Zhao et al., 2010) . In vitro, Cd binds to human ERa with high affinity in a noncompetitive manner, increases ER-mediated proliferation, induces the expression of estrogen-responsive genes, and impairs DNA repair (Brama et al., 2007; Jin et al., 2003; Siewit et al., 2010; Stoica et al., 2000; Fechner et al., 2011) . On the other hand, Cd can also activate nongenomic signaling via Erk1/2 MAPK and Akt phosphorylation (Brama et al., 2007; Liu et al., 2008) . However, it is currently unclear whether these biological activities of Cd take place in vivo, and if so, under what exposure levels.
The present study is a part of our effort to characterize the details of the estrogen-like activity of Cd in vivo using both female and male estrogen reporter (ERE-luciferase) mice. In our previous study, we investigated estrogen-like effects of CdCl 2 in immature female mice (Ali et al., 2010) . We did not detect uterine weight changes or reporter gene activation in the dose range of 5-500 lg/kg bw for a 3-day dosing regimen. Nevertheless, we observed significant thickening of uterine epithelia and activation of Erk1/2 kinase in the liver of these mice, suggesting that Cd may induce limited scope of estrogen-like effects. In the present study, we elaborate these findings further by broadening our scope from the ''disruption of estrogen signaling'' to a more general concept of ''disruption of cellular signaling'' by adding several additional molecular markers as well as one low-dose group (0.5 lg CdCl 2 /kg bw) to the study. We assessed the markers of general cellular stress (p53, p38, and Mdm2), activation of mitogenic kinases (Erk1/2 and Akt), markers of metal exposure, metallothionein 1 (Mt1) and metallothionein 2 (Mt2), and various transcriptional endpoints that could be activated by phosphorylation cascades, stress reactions, or by estrogen signaling, including immediate early response genes (c-myc, c-fos, and c-jun), stress response gene (HSP32), and ERa, in the liver of male mice. In addition, we evaluated the sensitivity of these molecular markers based on benchmark dose (BMD) analysis. Our data suggest that the mitogenic kinases and cellular stress signaling are affected by clearly lower doses of Cd than, for instance, the traditional markers of metal exposure, Mt1 and Mt2. These pathways may also represent a mechanism for the suggested endocrine modulatory activities of Cd.
MATERIALS AND METHODS
Animals. Six-week-old male mice carrying an estrogen-responsive reporter gene construct (3xERE-TATA-luciferase) consisting of trimerized ERE coupled to a minimal TATA-box driving the expression of luciferase were used in this study (Lemmen et al., 2004) . The animals were obtained from the local colony at the University of Turku (Turku, Finland) where the experiment was carried out under the ethical license numbers 1592/05 and ESLH-2007-03984. All experimental animals were kept under standard housing conditions on a 12:12 light/dark cycle at a room temperature 22 ± 1°C and relative humidity 50-60%. Animals had free access to tap water and to the semisynthetic AIN-93G rodent diet (Special Diet Services, Whitham, Essex, U.K.) as in our previous study (Ali et al., 2010) .
Subcutaneous injection of CdCl 2 and EE2. Mice were assigned to receive CdCl 2 (Sigma, St Louis, MO) dissolved in sterile PBS at 0.5 (n ¼ 6), 5 (n ¼ 6), 50 (n ¼ 6), or 500 lg/kg bw (n ¼ 6) per day for three consecutive days via subcutaneous (sc) injections in the neck. Control animals (n ¼ 6) were injected with vehicle only. Estrogen control animals received 50 lg/kg bw EE2 (Sigma) dissolved in corn oil (n ¼ 6).
Euthanasia, tissue collection, and preservation. Three days after the first injection, the mice were euthanized by CO 2 asphyxiation and weighed. Subsequently, whole blood was drawn by heart puncture, and tissues (brain, pituitary gland, ventral prostate, testis, liver, kidney, heart, and lungs) were collected, snap frozen in liquid nitrogen, and stored at À80°C until analysis. Liver, kidney, and bw were recorded at sacrifice, and one piece of liver, kidney, and whole blood were taken separately into sterile acid washed microcentrifuge tubes (StarLab, Ahrensburg, Germany) for later Cd analysis. One testis was collected in Bouin's fixative for later histological evaluation.
Cd analysis. Cd analysis in the whole blood, liver, and kidney was carried out as previously described (Ali et al., 2010) . The limit of detection (LOD) was 0.004 ng/g, calculated as mean of digested blanks þ 3 SDs. All measured concentrations were above the calculated LOD.
Luciferase activity measurements. Luciferase activity was measured using BioThema's Luciferase Assay kit (Haninge, Sweden) in 96-well plates (Greiner, Frickenhausen, Germany) with the same methodology as previously described (Ali et al., 2010) .
Western blot analysis of Erk, pErk, Akt, pAkt, pMdm2, p-p38, and p53 in liver. The protein contents were quantified in liver homogenates by using Coomassie Plus Protein Assay Reagent (Pierce, Täby, Sweden). The samples were subjected to SDS-PAGE, and the separated proteins were transferred to a polyvinylidene difluoride membrane (Bio-Rad, Hercules, CA) and subsequently probed with primary antibodies; phospho-Mdm2 Histological evaluation of the testis. Six-micrometer thick sections of paraffin embedded testes were mounted on microscopic slides (MENZEL-GLAZER, SuperFrost Plus, Germany) followed by clearing, rehydration, and staining with hematoxylin and eosin (Fischer et al., 2006) . All sections (5-6 sections per animal) were examined under light microscope (DIAPLAN, Leitz, Wetzlar, Germany), and the diameters of the seminiferous tubules and the thickness of epithelia were determined (10 measurements per testis) using a morphometric program (Leica IM500 Version: 4.0, Leica Microsystems Imaging Solutions Ltd., Cambridge, U.K.).
Gene expression in liver. RNA extraction procedure was adopted from the method provided by OMEGA Biotek, E.Z.N.A. total RNA Kit (VWR International AB, Karlskoga, Sweden). Briefly, 10 mg of liver tissue sample was homogenized in lysis buffer and applied to HiBind RNA spin column, and extraction was made according to the protocol provided with the kit. The concentration and the purity of RNA were determined by a Thermo Scientific NanoDrop 1000 spectrophotometer (Saveen & Werner, Limhamn, Sweden) . Approximately, 2 lg of total RNA was reverse transcribed into cDNA by using High Capacity RNA-to-cDNA kit (Applied Biosystems, Foster City). Following the first strand cDNA synthesis, PCR amplification was carried out using the Maxima SYBR Green qPCR Master Mix (2X) kit (FERMENTAS GMBH, Baden-Württemberg, Germany) according to the manufacturer's instructions, and quantification was made by 7500 real-time PCR System (Applied Biosystems). Primer sequences and product sizes are given in Supplementary table 1.
Statistical analysis. One-way ANOVA was employed to compare the effects among different treatment groups. Where significant differences were ESTROGEN-LIKE EFFECTS OF CADMIUM observed, we applied Dunnett's multiple comparison test to make post hoc comparisons between the means of vehicle controls and treatments. Differences were considered significant at p < 0.05 for two-tailed tests. All the statistical analyses were performed by GraphPad Prism version 5.04 for Windows, GraphPad Software, San Diego, CA, www.graphpad.com.
BMD analysis. BMD analysis was performed using a family of exponential models (PROAST version 18.2 in R software). As formal criteria to select a member from this family of models, the likelihood ratio test was used. The European Food Safety Authority (EFSA) guidelines suggest that for continuous endpoints, 5% benchmark response (BMR) levels should be used as default (EFSA, 2009 ). However, we selected 100% BMR level for BMD estimation because the studied genes are intermediate signaling molecules and do not directly represent the effect in general. In addition, benchmark dose levels (BMDL), i.e., BMD at the lower bound of the 95% confidence interval (CI), the BMD/BMDL ratio, which is a measure of the statistical uncertainty where a ratio greater than 10 is not acceptable, and the maximal response was also determined (Slob, 2002) .
RESULTS

Cd Concentrations in Blood, Kidney, and Liver
We verified the effectiveness of dosing by measuring the internal dose of Cd after treatment in blood, liver, and kidney. Compared with the vehicle-treated controls, significant elevation in Cd accumulation into kidneys and blood was observed after exposure to 50 lg CdCl 2 /kg bw and above and into liver after exposure to 500 lg CdCl 2 /kg bw (Fig. 1) . Highest concentrations were measured in the liver in these two Cd exposure groups, the concentrations in kidney remained on a twofold lower level and in blood on a 100-fold lower level as compared with liver ( Fig. 1) . Cd concentrations in EE2-treated animals, and in animals treated with 0.5-5 lg CdCl 2 /kg bw, did not significantly differ from vehicle-treated controls.
In addition to traditional statistics, we applied the BMD method to tissue Cd accumulation data in order to evaluate which doses lead to a 100% increase (twofold over background) of Cd accumulation in blood, liver, and kidney. The critical exposure doses were 0.9, 1.5, and 0.4 lg/kg bw for blood, kidneys, and liver, respectively (Table 2) .
Body Weights, Organ Weights, and Testis Histology
No significant differences in the liver, kidney, or bw were observed between the groups after exposure to CdCl 2 (Table 1) . Furthermore, testicular histology analysis also revealed no marked changes in the tubulus diameter or epithelial thickness at stage VII of spermatogenesis (Supplemental Fig. 1 ), suggesting lack of overt toxicity of the CdCl 2 doses used in this study.
Luciferase Activity
We measured the luciferase activity in reproductive and nonreproductive organs to assess the effect of CdCl 2 on canonical estrogen signaling. After EE2 exposure, luciferase activity was significantly increased in all the analyzed tissues/ organs, compared with vehicle-treated controls (Fig. 2) . However, no significant changes in luciferase activity were detected in any of the CdCl 2 -treated groups.
Phosphorylation of Mitogenic Kinases
We carried out Western blots analysis on liver homogenates in order to quantify the phosphorylation of MAPKs Erk1/2 and Akt in response to CdCl 2 treatment. In agreement with our previous study in female mice, the estrogen control EE2 did not significantly alter the phosphorylation of these kinases, whereas CdCl 2 did significantly increase the phosphorylation of Erk1/2 at Tyr 204 (at doses 0.5-50 lg/kg bw) and had no effects on the phosphorylation of Akt at Ser 473 (Fig. 3) . Furthermore, total protein contents of Erk1 and Akt1 were not altered after CdCl 2 and/or EE2 treatment as compared with control (Fig. 3A) .
FIG. 1. Dose-dependent increase in blood, liver, and kidney Cd concentration: Cd concentration (ng/g) in the blood, kidney, and liver after sc exposure to 0.5-500 lg CdCl 2 /kg bw, 50 lg EE2/kg bw, or vehicle (Ctrl) for three consecutive days. Results represent mean ± SEM; *p < 0.05; **p < 0.01; ***p < 0.001, significantly different from the vehicle-treated control group; ANOVA þ Dunnett's multiple comparison test. 24.7 ± 1.0 50.0 ± 3.6 13.6 ± 1.8 CdCl 2 0.5 6 27.2 ± 0.8 46.1 ± 5.2 13.5 ± 2.2 CdCl 2 5 6 25.0 ± 2.2 47.2 ± 7.7 13.8 ± 0.7 CdCl 2 50 6 27.6 ± 2.5 51.2 ± 4.0 13.1 ± 1.0 CdCl 2 500 6 26.1 ± 1.2 49.6 ± 3.4 13.8 ± 0.8 EE2 50 6 25.2 ± 1.7 51.5 ± 6.4 13.9 ± 0.7
Note. Data shown as mean ± SD; no significant differences between treatments and the control; ANOVA. 68 ALI ET AL.
Cellular Stress Responses
We quantified the activation of p38 MAPK, p53, and Mdm2, in order to assess the cellular stress response in liver. All markers showed dose-dependent activation in response to CdCl 2 treatment (Fig. 4) . Cd treatment significantly increased the phosphorylation of p38 starting at 50 lg/kg bw CdCl 2 dose and the p38 transcript at the highest exposure level (Figs. 4B and E). Also, EE2 increased the p38 mRNA expression. p53 was also significantly induced on both protein and mRNA level after treatment with 500 lg/kg bw CdCl 2 and after treatment with EE2 (Figs. 4C and F) . Finally, the amount of Mdm2 transcript in the liver was increased by the highest dose of CdCl 2 , and the phosphorylated Mdm2 protein was increased by 5 lg CdCl 2 /kg bw. EE2 treatment on the other hand decreased the phosphorylated Mdm2 protein levels but not the Mdm2 mRNA (Figs. 4D and G) .
Activation of Endogenous Genes
The expression levels of metallothioneins Mt1 and Mt2, and the proto-oncogene c-fos, were significantly increased in the highest dose CdCl 2 -treated group (Fig. 5) . However, CdCl 2 had no significant effects on the expression of c-myc, c-jun, HSP32, or ERa. The estrogen control EE2 significantly increased the expression of c-myc and HSP32 (Fig. 5) .
BMD Modeling of Molecular Markers of Cd Exposure
In addition to ANOVA, to test statistically significant differences in our datasets, we also applied the BMD method. This method fits a curve to the whole dataset, instead of handling the treatment groups individually. Using the fitted curves, we then calculated the CdCl 2 dose level, BMD, which corresponds to the dose that give twice the effect over the background effect level. Corresponding BMDL values, i.e., the lower bound of the 95% CI of BMD, were likewise calculated. The responses to which the BMD method could be successfully applied were mRNA expression of Mt1, Mt2, p53, c-fos, and Mdm2. The other markers either did not comply with traditional dose-response models or the fitted curves displayed too high level of uncertainty (BMD/BMDL > 10). The BMDL values ranged from 7.6 lg/kg bw for the expression of p53 to 259 lg/kg bw for the expression of c-fos (Table 2 ). The curves fitted to the data, as well as fit parameters, are available in Supplementary figure 2.
FIG. 2.
Lack of effects on luciferase activity after CdCl 2 exposure in vivo: Tissue-specific expression of luciferase (RLU/mg protein) in liver, kidney, brain, heart, lung, testis, ventral prostate, and pituitary gland, after sc exposure to 0.5-500 lg CdCl 2 /kg bw, 50 lg EE2/kg bw, or vehicle for three consecutive days. Results represent median and range; *p < 0.05; **p < 0.01; ***p < 0.001, significantly different from the vehicle-treated control group; ANOVA þ Dunnett's multiple comparison test.
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DISCUSSION
The present study was undertaken to confirm the results from our previous study (Ali et al., 2010) and to elaborate on the mode of action of Cd that may lead to estrogen-like effects in vivo in the absence of effects on the canonical estrogen signaling. Our new data from males confirm the main findings from our previous study in females, and further strengthens our hypothesis that the endocrine modulatory effects of Cd in vivo may involve stress responses and membrane-associated events instead of bona fide estrogen-signaling pathway.
Toxic Versus Endocrine Modulative Exposure Levels
In humans, occupational exposure to Cd is considered to increase risk of lung and prostate cancer (IARC, 1993) . In rodents, Cd toxicity manifests itself as causation of tumors at various tissue sites that may include prostate, testicular, adrenal gland, pituitary gland, lung, liver, and kidney. The tumor formation requires milligrams per kilogram body weight exposure levels by injection, several months of time to develop, and the incidence of tumors increased with increasing exposure levels (National Toxicology Program, 2011). Furthermore, testis is known to be very sensitive to Cd exposure, at least in rodents, where hemorrhage can be observed within hours of exposure to milligrams per kilogram body weight doses of Cd salts (Siu et al., 2009 ).
Based on animal models, the endocrine modulatory effects of Cd, on the other hand, are expected to occur at subtoxic, environmentally relevant exposure levels. For instance, significant uterotrophic and mammary gland stimulatory activity were first observed to take place after short exposure to 5 lg/kg bw Cd (Johnson et al., 2003) . The dose levels we have chosen for our study start from 0.5 lg/kg bw (total dose 1.5 lg/kg bw in the 3-day exposure), which represents well the safe, 2.5 lg/kg tolerable weekly intake value set by EFSA for life-long dietary Cd exposure in humans. To be sure that our dose range was not acutely toxic to the animals, we compared the weights of liver and kidneys, major sites of Cd accumulation, and investigated the testicular histology. We did not detect any alterations, which suggests that our study settings are suitable for evaluating endocrine modulatory effects of Cd.
CdCl 2 Does Not Activate ERE-luc Reporter Gene
Despite significant accumulation of Cd to the inner organs and blood, we could not detect activation of the estrogen responsive ERE-luc reporter gene. This is in line with our previous findings in female mice (Ali et al., 2010) . Liver and kidneys, in addition to being the major sites of Cd accumulation, are also among the most responsive tissues in terms of estrogen stimulated ERE-luc expression in our mouse model (Lemmen et al., 2004; Damdimopoulou FIG. 3 . Effects on mitogenic kinases: Western blots and densitometry analysis of phosphorylated Erk1/2, total Erk, phosphorylated Akt, and total Akt in liver homogenates after sc exposure to 0.5-500 lg CdCl 2 /kg bw, 50 lg EE2/kg bw, or vehicle for three consecutive days. et al., 2011). The fact that Cd did not stimulate the reporter gene in these tissues at any of the concentrations tested strongly suggests lack of agonistic interaction with the ER, at least in the classical EREmediated pathway. Recent biosensor-based profiling of Cd-ER interaction similarly suggests that Cd is unable to promote agonistic conformation in ERa (Fechner et al., 2011) .
CdCl 2 Promotes Mitogenic Signaling in Liver
Estrogen signaling not only leads to modulation of transcription in the cell nucleus but also triggers rapid membrane-associated signaling events in the cell. Interestingly, it seems that environmental estrogen disrupters have distinct effect profiles when tested for nongenomic and genomic effects as a function of time and concentration in vitro (Bulayeva and Watson, 2004; Silva et al., 2010) . In the present   FIG. 4 . Stress responses: Western blots, densitometry analysis, and quantitative real time-PCR analysis of p38, p53, and Mdm2 in liver homogenates after sc exposure to 0.5-500 lg CdCl 2 /kg bw, 50 lg EE2/kg bw, or vehicle for three consecutive days. (A) Representative Western blots, (B) phosphorylated p38, (C) total p53 protein, (D) phosphorylated Mdm2, (E) p38 mRNA, (F) p53 mRNA, and (G) Mdm2 mRNA. Results represent mean ± SEM; *p < 0.05; **p < 0.01; ***p < 0.001, significantly different from the vehicle-treated control group; ANOVA þ Dunnett's multiple comparison test.
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71 study, we observed that Cd activated Erk1/2 in the low-dose groups, and similar observations of Erk1/2 activation by Cd have been previously published by others in cell culture (Brama et al., 2007; Liu et al., 2008; Zang et al., 2009) . It is possible that Cd, like other endocrine modulators, has an effect profile that changes with time, and it remains to be studied if the higher doses would have activated mitogenic signaling for instance in shorter time exposure. Nevertheless, the low-dose 3-day exposure led to Erk1/2 activation in the liver, which is noteworthy, because kinase activation is typically rapid and FIG. 5. Endogenous gene expression in response to CdCl 2 exposure: Normalized expression of Mt1, Mt2, c-myc, c-fos, c-jun, HSP32, and ER-a in liver tissue after sc exposure to 0.5-500 lg CdCl 2 /kg bw, 50 lg EE2/kg bw, or vehicle for three consecutive days. All genes of interest were normalized with control housekeeping genes TATA box binding protein (TBP) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH). Data are presented as fold change with vehicle control set as 1. *p 0.5; **p 0.01; ***p 0.001, significantly different from the vehicle-treated control group; ANOVA þ Dunnett's multiple comparison test. 72 ALI ET AL. transient. Perhaps Cd, at least at certain doses, can promote sustained Erk1/2 activation in vivo, as has been suggested in vitro by others (Zang et al., 2009) .
Erk1/2 is a major cellular signaling pathway activated by mitogens to promote proliferation. Indeed, the typical MAPK inducer, insulin-like growth factor, promotes proliferation of uterine epithelia in mice (Winuthayanon et al., 2010) . In previous work, we observed significant thickening of uterine epithelia in response to Cd treatment (Ali et al., 2010) . It seems plausible that this is mediated through MAPK activation. However, it remains to be studied whether Cd activates MAPK through ER located at cell membrane or through other receptors, such as GPR30 (Yu et al., 2010) . The direct involvement of membrane-associated tyrosine kinases should not be ruled out either because, for instance, the epidermal growth factor receptor can be activated by a variety of metals including arsenic and zinc, and the activity of c-Src can be regulated by mercury (Wu et al., 1999; Senga et al., 2008) .
High Doses of CdCl 2 Induce Stress Signaling
High and low doses of CdCl 2 had distinct response profiles in our study: while the low doses activated MAPK, the higher doses induced transcriptional changes that relate to cellular stress. The stress-induced MAPK p38 was induced both on protein and mRNA level by 500 lg CdCl 2 /kg bw. p53 was likewise increased both on mRNA and protein level in the high-dose group. Both p38 and p53 are known as cellular stress sensors, the activation of which can lead to a delay in the cell cycle, and cellular senescence or apoptosis. Accumulation of p53 is known to be induced by, e.g., DNA damage. Because Cd can induce DNA damage through interference with DNA repair mechanisms and production of reactive oxygen species (Joseph, 2009) , we detected the protein levels of DNA damage-associated marker, histone variant H2AX, in liver samples. However, we did not find any significant changes between the groups (data not shown), suggesting that the concentrations of Cd, or treatment time, used in our study are not sufficient to cause detectable genotoxic stress. Cd ions are very reactive and in particular bind to sulfhydryl groups present for instance in amino acids and also can replace Zn as a cofactor in different enzymes. This type of interference with protein structure/function could represent another form of cellular stress caused by Cd that could lead to activation of stress signaling. The induction in p53 gene expression after CdCl 2 exposure in our study supports the findings by Zheng et al. (1996) and Zhou et al. (1999 Zhou et al. ( , 2004 .
Metallothioneins 1 and 2, well known markers of metal exposure, were induced only at the highest exposure level (500 lg/kg bw) in our study. This observation, combined with the fact that other significant transcriptional responses only took place in the high-dose group, suggests that a threshold concentration exists for the induction of nuclear activities by Cd. Such threshold could depend on a bottleneck in cellular uptake of Cd or on neutralizing effect of an existing pool of proteins capable of sequestering Cd at low doses. Alternatively, the differences in low-and high-dose group responses could depend on differing interplay between nongenomic and genomic signaling in the respective groups. Perhaps higher doses of CdCl 2 stimulated a strong initial MAPK activation that significantly contributed to subsequent activation of transcriptional responses. Because we had one time point in our study, it is hard to speculate on the timing of the signaling events, and these issues should be further studied in cell culture.
Modeling Effects of Cd on Cellular Signaling
Our study is unique in covering a concentration range over four orders of magnitude and encompassing an area where dose-response effects are observed. These features enable us to carry out the first BMD modeling of the effects of Cd on cellular-signaling pathways in vivo. BMD approach has been Note. Data shown is derived from simultaneous fitting of the model to male mice after CdCl 2 treatment. Ratio BMD/BMDL is a measure of statistical uncertainty; a maximum of 10 is acceptable. Maximal response is the difference from background as a percentage, calculated from background and average of the dose group with a maximal response.
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proposed to provide a quantitative alternative to the NOAEL method for setting limit values for noncancer health effects, with a main advantage being that BMD is not limited to one experimental dose but instead uses information from all dose groups. In our study, BMDL for different responses to Cd in the order of their sensitivity are p53 > Mt2 > Mdm2 > Mt1 > c-fos (all mRNA), indicating p53 induction (BMDL 7.6 lg/kg bw) as a highly sensitive response. However, these BMDLs are still substantially higher than 0.5 lg CdCl 2 /kg bw, the dose required to significantly phosphorylate Erk1/2.
In general, the activation of mitogenic kinases such as Erk1/2 leads to cell proliferation and can also promote thickening of epithelia in the rodent uterus. As uncontrolled proliferation in turn could contribute to the initiation of cancer, the observed low-dose effect of Cd on MAPK should be studied further. In addition, the activation of the tumor suppressor p53 by relatively low levels of Cd exposure clearly suggests increased cellular stress, which in a prolonged exposure scenario could lead to cancer development.
When examining the dose and sensitivity of responses in our data, two different response profiles emerge: on one hand, low doses stimulate mitogenic MAPK signaling, and on the other hand, high doses stimulate stress signaling and modulate transcription. Such strictly concentration-dependent responses have been suggested for Cd before. Jiang et al. (2009) studied the effect of CdCl 2 in human embryo lung fibroblasts and concluded that at low concentrations Cd stimulates cell proliferation through an Erk1/2 sensitive mechanism, whereas high concentrations stimulates p-p38 and inhibit proliferation (Jiang et al., 2009 ).
CONCLUSIONS
After two separate studies, we can now conclude that Cd does not activate canonical estrogen signaling in vivo, as indicated by the lack of effect on the ERE-luc transgene in 14 different tissues in males and females (present study and Ali et al., 2010) . Furthermore, Cd does not stimulate uterine weight increase, the hallmark of estrogen activity, at environmentally relevant doses (Ali et al., 2010) . However, Cd is able to stimulate cellular signaling pathways, such as MAPK signaling, that could reproduce effects reminiscent of estrogenicity, such as thickened uterine epithelium (Ali et al., 2010) . A collective analysis of our data indicates that the most similar response patterns between Cd and EE2 in our 3-day exposure studies were observed in the activation of p38 and p53, which suggests that stimulation of stress sensors could be a common denominator in Cd-and estrogen-induced effects. We hypothesize that selective modulation of ERs is involved in the mode of action of Cd and that additional signaling pathways and receptors are likely to be involved too. In conclusion, we propose that the apparent estrogen-like activity of Cd is likely to stem from a mechanism different from that of steroidal estrogens. 
